PSTXPoseida Therapeutics Inc

$9.50
$0.06
(0.63%)
Today
Closed $9.50
$0.04
(0.42%)
After Hours
Updated: 07:41 PM EST
Reported EarningsNov 7
Mkt Cap$925.92M
Vol21.42M

About

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Poseida Therapeutics Inc?
What is the 52-week high for Poseida Therapeutics Inc?
What is the 52-week low for Poseida Therapeutics Inc?
What is Poseida Therapeutics Inc stock price today?
What was Poseida Therapeutics Inc stock price yesterday?
What is the PE ratio of Poseida Therapeutics Inc?
What is the Price-to-Book ratio of Poseida Therapeutics Inc?
What is the 50-day moving average of Poseida Therapeutics Inc?

Advertisement|Remove ads.